Join to View Full Profile
928 Mears CountStanford, CA 94305
Phone+1 650-723-1922
Fax+1 650-498-6262
Dr. Andreasson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1989 - 1992
University of MarylandInternship, Internal Medicine, 1988 - 1989
Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
CA State Medical License 2007 - 2024
MD State Medical License 1993 - 2006
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration.Friederike Grandke, Tobias Fehlmann, Fabian Kern, David M Gate, Tobias William Wolff
Nature Communications. 2025-02-25 - 1 citationsPlasma Aβ/Aβis sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum.Alexandra N Trelle, Christina B Young, Hillary Vossler, Javier Ramos Benitez, Karly A Cody
Alzheimer's & Dementia. 2025-02-01 - F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease.Joseph R Winer, Hillary Vossler, Christina B Young, Viktorija Smith, America Romero
Brain Communications. 2025-01-01
Journal Articles
- Macrophage De Novo NAD+ Synthesis Specifies Immune Function in Aging and InflammationRavindra Majeti, Paras S Minhas, Katrin I Andreasson, Christopher Dove, Nature
Press Mentions
This Metabolic Brain Boost Revives Memory in Alzheimer’s MiceSeptember 2nd, 2024- Could a Cancer Drug Help Treat Early Alzheimer’s? Study Offers CluesAugust 26th, 2024
- Alzheimer’s: Cancer Drug Could Cure It in Early StageAugust 25th, 2024
- Join now to see all
Grant Support
- Metabolic mechanisms of cognitive decline in aging and AD mediated by inflammatory PGE2 signalingSTANFORD UNIVERSITY2023–2026
- Reprogramming myeloid cell metabolism to prevent cognitive aging and Alzheimer's DiseaseSTANFORD UNIVERSITY2021–2026
- The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's diseaseSTANFORD UNIVERSITY2022–2025
- The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's diseaseSTANFORD UNIVERSITY2019–2025
- The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's diseaseSTANFORD UNIVERSITY2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
